Johnson & Johnson vs AstraZeneca PLC
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Both companies need to be compared on revenue growth quality, margin trajectory and management commentary.
Johnson & Johnson and AstraZeneca PLC show active capex signals based on earnings call analysis.
No strong fundraising signal is currently visible for either company.
| Metric | Johnson & Johnson | AstraZeneca PLC |
|---|---|---|
| Current Price | ₹230.8 | ₹185.33 |
| Market Cap | ₹5.56 L Cr. | ₹5.75 L Cr. |
| Industry | Pharmaceuticals | Pharmaceuticals |
| P/E Ratio | 26.672073 | 28.148872 |
| ROE (%) | — | — |
| Debt/Equity | — | — |
| Sales Growth 5Y (%) | — | — |
| Profit Growth 5Y (%) | — | — |
| Promoter Holding (%) | — | — |
| Revenue Rank | Rank 3 | Rank 3 |
| Margin Rank | Rank 4 | Rank 3 |
| Signal | — | — |
| Capex | Yes | Yes |
| Fundraise | No information | No information |